Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
clinical trials
microbiome
pfizer
abbvie
abeona therapeutics
astrazeneca
avexis
biontech
brian kaspar
bristol-myers squibb
cancer
What
roundup
bio
biotech
drug
news
according
acquisitions
advantages
akcea
august
bar
biggest
brings
build
busy
buy
cases
centers
ceo
cigarettes
company’s
control
daniel
days
deaths
debut
decisions
devices
disease
drugs
dyne’s
electronic
expect
fda
gamble
gilead
including
injuries
legacy
linked
Language
unset
4
×
Current search:
novartis
×
amgen
×
" indiana top stories "
×
unset
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More